GENE ONLINE|News &
Opinion
Blog

RSV vaccines
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
The First Approved RSV Vaccine Worldwide Belongs to AstraZeneca and Sanofi
2022-11-06
GSK’s RSV Vaccine Candidate Has Won Another Regulatory Review
2022-11-03
GSK Posts Stellar Results from Phase 3 RSV Vaccine Trial
2022-10-13
AstraZeneca, Sanofi’s RSV Antibody Recommended For Approval In EU
2022-09-19
Pfizer’s Bivalent RSV Candidate Demonstrates 85% Efficacy in Phase 3 Trials
2022-08-26
ReViral Acquisition by Pfizer To Enhance Its Respiratory Syncytial Virus Therapeutic Portfolio
2022-04-10
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!